88 related articles for article (PubMed ID: 16650524)
1. Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway.
Grey A; Zhu Q; Watson M; Callon K; Cornish J
Mol Cell Endocrinol; 2006 Jun; 251(1-2):96-102. PubMed ID: 16650524
[TBL] [Abstract][Full Text] [Related]
2. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells.
Grey A; Banovic T; Zhu Q; Watson M; Callon K; Palmano K; Ross J; Naot D; Reid IR; Cornish J
Mol Endocrinol; 2004 Sep; 18(9):2268-78. PubMed ID: 15178744
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin and bone; structure-activity relationships.
Cornish J; Palmano K; Callon KE; Watson M; Lin JM; Valenti P; Naot D; Grey AB; Reid IR
Biochem Cell Biol; 2006 Jun; 84(3):297-302. PubMed ID: 16936800
[TBL] [Abstract][Full Text] [Related]
4. Insulin induces the low density lipoprotein receptor-related protein 1 (LRP1) degradation by the proteasomal system in J774 macrophage-derived cells.
Ceschin DG; Sánchez MC; Chiabrando GA
J Cell Biochem; 2009 Feb; 106(3):372-80. PubMed ID: 19115269
[TBL] [Abstract][Full Text] [Related]
5. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone.
Niemeier A; Kassem M; Toedter K; Wendt D; Ruether W; Beisiegel U; Heeren J
J Bone Miner Res; 2005 Feb; 20(2):283-93. PubMed ID: 15647823
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways.
Raucci A; Bellosta P; Grassi R; Basilico C; Mansukhani A
J Cell Physiol; 2008 May; 215(2):442-51. PubMed ID: 17960591
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.
Dufour C; Holy X; Marie PJ
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E794-801. PubMed ID: 18378961
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin as an effector molecule in the skeleton.
Cornish J; Naot D
Biometals; 2010 Jun; 23(3):425-30. PubMed ID: 20232111
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis.
Kim L; Denkers EY
J Cell Sci; 2006 May; 119(Pt 10):2119-26. PubMed ID: 16638808
[TBL] [Abstract][Full Text] [Related]
13. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
15. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
16. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin promotes collagen gel contractile activity of fibroblasts mediated by lipoprotein receptors.
Takayama Y; Takezawa T
Biochem Cell Biol; 2006 Jun; 84(3):268-74. PubMed ID: 16936796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
